Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients — Update | Morningstar

Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients — Update
By Stephen Nakrosis
Eli Lilly said the Food and Drug Administration approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity.
Read more...